Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

TBIO

Telesis Bio (TBIO)

Telesis Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TBIO
일자시간출처헤드라인심볼기업
2025/01/0714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TBIOTelesis Bio Inc
2025/01/0714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TBIOTelesis Bio Inc
2025/01/0406:20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:TBIOTelesis Bio Inc
2025/01/0406:18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:TBIOTelesis Bio Inc
2024/11/0906:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/09/2605:05GlobeNewswire Inc.Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA SynthesisNASDAQ:TBIOTelesis Bio Inc
2024/09/2106:02Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:TBIOTelesis Bio Inc
2024/09/1105:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/09/1105:30GlobeNewswire Inc.Telesis Bio Plans to Delist its Securities from The Nasdaq Stock MarketNASDAQ:TBIOTelesis Bio Inc
2024/08/3106:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/08/2906:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/08/2105:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/08/0819:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
2024/08/0805:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/08/0805:05GlobeNewswire Inc.Telesis Bio Reports Second Quarter and First Half 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
2024/07/2705:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
2024/07/2705:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
2024/07/2605:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
2024/07/2605:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
2024/07/1906:42Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
2024/07/1906:32Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
2024/07/1906:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/06/1306:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/06/1109:40Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
2024/06/1109:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
2024/05/1019:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
2024/05/1005:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/05/1005:05GlobeNewswire Inc.Telesis Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
2024/05/0705:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
2024/05/0705:05GlobeNewswire Inc.Telesis Bio Announces Reverse Stock SplitNASDAQ:TBIOTelesis Bio Inc
 검색 관련기사 보기:NASDAQ:TBIO